American Medical Technologies Inc.
ADLI · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -14.6% | 8.9% | -9.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 63.7% | 67.4% | 69.8% | 53.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 15.1% | 7.8% | 29.8% | 20.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | -$0 | -$0 | -$0 |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -19.7% | 24.3% | 0.7% | 19.3% |
| EPS | -0.011 | 0.02 | 0.001 | 0.02 |
| % Growth | -156.5% | 3,900% | -97.5% | – |
| EPS Diluted | -0.011 | 0.02 | 0.001 | 0.02 |
| Weighted Avg Shares Out | 10 | 10 | 10 | 10 |
| Weighted Avg Shares Out Dil | 10 | 10 | 10 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | -$0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7.3% | -0.4% | -21.7% | -13% |